Changzhou Qianhong Biopharma CO.,LTD reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was CNY 608.22 million compared to CNY 552.22 million a year ago. Revenue was CNY 608.22 million compared to CNY 552.22 million a year ago.

Net income was CNY 85.95 million compared to CNY 128.25 million a year ago. Basic earnings per share from continuing operations was CNY 0.0672 compared to CNY 0.1026 a year ago. Diluted earnings per share from continuing operations was CNY 0.0672 compared to CNY 0.1026 a year ago.